[2/14 3rd Fraud Countermeasures Study Group] A lawyer who is familiar with fraud and forensic investigations and the customer success manager of the AI audit system talk about what is a normal audit that does not fail?
Due to the increase in audit data due to the diversification of communication methods and the diversification of management risks such as cartels, information leaks, and harassment, regular audits for fraud prevention are becoming more and more difficult these days.
In order to prevent fraud and minimize damage after fraud is discovered, regular audits are very important, and corporate legal affairs personnel are often overwhelmed by the construction of an audit system. Isn't there a lot of people who are in the middle of the day?
An increasing number of companies are introducing AI in order to reduce the burden on people in the field performing regular audits and to improve the quality of audits.
In this study session, Mr. Toda from TMI Law Office, who has extensive experience in corporate fraud and forensic investigations and the construction of recurrence prevention systems, will explain how to proceed with regular audits from a practical perspective. In addition, we will explain how to conduct normal audits that do not fail while having a dialogue with the customer success manager who supports the introduction of AI.
◆Title: 3rd Fraud Countermeasures Study Session “What is a normal audit that does not fail, discussed by a lawyer who is familiar with fraud and forensic investigations and the customer success manager of the AI audit system? 』
◆ Date: May 2023, 2 (Tuesday) 14: 15-00: 16
◆ Webinar type: Zoom Webinar
Director of TMI Privacy & Security Consulting
Chuo University Law School Concurrent Lecturer (Asia Business Law)
Kentaro Toda
Global compliance advice and forensics such as antitrust law / competition law, overseas bribery regulation, international trade (economic sanctions, anti-dumping), business and human rights, whistleblower protection law, establishment of global governance system, etc. Information governance is the main field of business, and in-house compliance training instructors are also energetically conducted.
FRONTEO Inc.
Director / AI Solution Business Management and President's Office Manager
Mari Yamamoto
After joining an advertising agency, she was enrolled in a risk management company.Launch the mental health care business, execute business plans, product development, marketing, and sales strategies, and lead to the top market share in the industry. In 2014, she became a director of the company and was listed on the First Section of the Tokyo Stock Exchange in 2017.
Joined FRONTEO Inc. in December 2018 and became a director in 12, managing and directing the entire AI solution business.
In the life science AI business, we will promote development in the digital health field such as diagnostic support and disease prediction using the artificial intelligence engine "Concept Encoder", and also in the drug discovery field, a drug discovery support AI system that supports speeding up the discovery of candidate compounds. To challenge new areas in life science.
In the business intelligence business, he uses the artificial intelligence engine "KIBIT" to direct the DX promotion of companies.We will also develop solutions that utilize AI in the field of economic security to support governments, government agencies, and companies.
Neurolinguistics Research Institute Customer Success Department Director
Eiji Goto
Articles in the same category
[Online seminar held on 5/30] Practical techniques for legal due diligence for M&A
[5/31 15th Fraud Countermeasures Study Session] [Must-see for compliance personnel] Mass media response in the event of a crisis
[Online seminar held on 5/9] New framework and practical outlook for European foreign investment regulations - Explanation of the European Commission's new regulation proposal and the regulatory environment of major countries -
[Real seminar held on 4/18] “Crisis management proposed by a competition law/consumer law boutique firm” ~Risk management to avoid a “crisis”~
Exploring patient stratification biomarkers for IgA nephropathy using AI: Overcoming bias with AI
Searching for therapeutic targets for pancreatic cancer - I tried using paper search AI -
Parkinson's disease - Analyzing drug discovery targets using paper search AI
Economic Security Symposium co-hosted by FRONTEO x Moody's Analytics Japan on April 4th
Searching for new targets for sporadic ALS using AI: Become friends with AI